TP53 and cancer: Next, we performed KEGG pathway enrichment analysis using DEGs between benign tumors and NIFTP/malignancy and found several cancer-associated pathways, including ECM-receptor interaction, MAPK signaling pathway, Ras signaling pathway, pathway in cancer, and p53 signaling pathway (Fig. 1B).